Go Pro

MYCELX Technologies (MYX) Competitors

MYCELX Technologies logo
GBX 50.13 +0.63 (+1.28%)
As of 11:14 AM Eastern

MYX vs. GRA, WYG, CTG, INCE, and SNX

Should you buy MYCELX Technologies stock or one of its competitors? MYCELX Technologies's main competitors and comparable companies include Grafenia (GRA), WYG (WYG), Christie Group (CTG), The Ince Group (INCE), and Synectics (SNX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "commercial services & supplies" industry.

How does MYCELX Technologies compare to Grafenia?

Grafenia (LON:GRA) and MYCELX Technologies (LON:MYX) are both small-cap industrials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

MYCELX Technologies has a net margin of 2.84% compared to Grafenia's net margin of -11.78%. MYCELX Technologies' return on equity of 7.39% beat Grafenia's return on equity.

Company Net Margins Return on Equity Return on Assets
Grafenia-11.78% -82.44% -4.07%
MYCELX Technologies 2.84%7.39%-24.82%

43.6% of Grafenia shares are owned by institutional investors. Comparatively, 18.1% of MYCELX Technologies shares are owned by institutional investors. 44.9% of Grafenia shares are owned by insiders. Comparatively, 30.4% of MYCELX Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Grafenia has a beta of 0.33, meaning that its stock price is 67% less volatile than the broader market. Comparatively, MYCELX Technologies has a beta of 1.255, meaning that its stock price is 26% more volatile than the broader market.

Grafenia has higher earnings, but lower revenue than MYCELX Technologies. Grafenia is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grafenia£11.68M0.00-£1.41M-£0.01N/A
MYCELX Technologies£11.74M1.04-£4.52M£1.0050.13

In the previous week, MYCELX Technologies had 1 more articles in the media than Grafenia. MarketBeat recorded 1 mentions for MYCELX Technologies and 0 mentions for Grafenia. Grafenia's average media sentiment score of 0.00 equaled MYCELX Technologies'average media sentiment score.

Company Overall Sentiment
Grafenia Neutral
MYCELX Technologies Neutral

Summary

MYCELX Technologies beats Grafenia on 7 of the 11 factors compared between the two stocks.

How does MYCELX Technologies compare to WYG?

WYG (LON:WYG) and MYCELX Technologies (LON:MYX) are both small-cap industrials companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

MYCELX Technologies has a net margin of 2.84% compared to WYG's net margin of 0.00%. MYCELX Technologies' return on equity of 7.39% beat WYG's return on equity.

Company Net Margins Return on Equity Return on Assets
WYGN/A N/A N/A
MYCELX Technologies 2.84%7.39%-24.82%

18.1% of MYCELX Technologies shares are owned by institutional investors. 30.4% of MYCELX Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

WYG has higher revenue and earnings than MYCELX Technologies. WYG is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WYG£154.43M0.00N/A-£6.70N/A
MYCELX Technologies£11.74M1.04-£4.52M£1.0050.13

In the previous week, MYCELX Technologies had 1 more articles in the media than WYG. MarketBeat recorded 1 mentions for MYCELX Technologies and 0 mentions for WYG. WYG's average media sentiment score of 0.00 equaled MYCELX Technologies'average media sentiment score.

Company Overall Sentiment
WYG Neutral
MYCELX Technologies Neutral

Summary

MYCELX Technologies beats WYG on 7 of the 9 factors compared between the two stocks.

How does MYCELX Technologies compare to Christie Group?

MYCELX Technologies (LON:MYX) and Christie Group (LON:CTG) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

18.1% of MYCELX Technologies shares are owned by institutional investors. Comparatively, 0.2% of Christie Group shares are owned by institutional investors. 30.4% of MYCELX Technologies shares are owned by company insiders. Comparatively, 61.4% of Christie Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Christie Group has higher revenue and earnings than MYCELX Technologies. Christie Group is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MYCELX Technologies£11.74M1.04-£4.52M£1.0050.13
Christie Group£70.60M0.55-£3.31M£5.0630.04

In the previous week, MYCELX Technologies had 1 more articles in the media than Christie Group. MarketBeat recorded 1 mentions for MYCELX Technologies and 0 mentions for Christie Group. Christie Group's average media sentiment score of 0.75 beat MYCELX Technologies' score of 0.00 indicating that Christie Group is being referred to more favorably in the news media.

Company Overall Sentiment
MYCELX Technologies Neutral
Christie Group Positive

MYCELX Technologies has a beta of 1.255, meaning that its share price is 26% more volatile than the broader market. Comparatively, Christie Group has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

MYCELX Technologies has a net margin of 2.84% compared to Christie Group's net margin of -4.87%. MYCELX Technologies' return on equity of 7.39% beat Christie Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MYCELX Technologies2.84% 7.39% -24.82%
Christie Group -4.87%-80.44%0.37%

Summary

MYCELX Technologies beats Christie Group on 7 of the 13 factors compared between the two stocks.

How does MYCELX Technologies compare to The Ince Group?

MYCELX Technologies (LON:MYX) and The Ince Group (LON:INCE) are both small-cap industrials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment.

In the previous week, MYCELX Technologies had 1 more articles in the media than The Ince Group. MarketBeat recorded 1 mentions for MYCELX Technologies and 0 mentions for The Ince Group. MYCELX Technologies' average media sentiment score of 0.00 equaled The Ince Group'saverage media sentiment score.

Company Overall Sentiment
MYCELX Technologies Neutral
The Ince Group Neutral

The Ince Group has higher revenue and earnings than MYCELX Technologies. The Ince Group is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MYCELX Technologies£11.74M1.04-£4.52M£1.0050.13
The Ince Group£102.47M0.37£1.37M£0.8711.89

MYCELX Technologies has a net margin of 2.84% compared to The Ince Group's net margin of 0.60%. MYCELX Technologies' return on equity of 7.39% beat The Ince Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MYCELX Technologies2.84% 7.39% -24.82%
The Ince Group 0.60%3.28%3.94%

18.1% of MYCELX Technologies shares are held by institutional investors. Comparatively, 15.3% of The Ince Group shares are held by institutional investors. 30.4% of MYCELX Technologies shares are held by company insiders. Comparatively, 9.9% of The Ince Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

MYCELX Technologies has a beta of 1.255, meaning that its share price is 26% more volatile than the broader market. Comparatively, The Ince Group has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market.

Summary

MYCELX Technologies beats The Ince Group on 8 of the 12 factors compared between the two stocks.

How does MYCELX Technologies compare to Synectics?

Synectics (LON:SNX) and MYCELX Technologies (LON:MYX) are both small-cap industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Synectics has a beta of 0.652, meaning that its stock price is 35% less volatile than the broader market. Comparatively, MYCELX Technologies has a beta of 1.255, meaning that its stock price is 26% more volatile than the broader market.

Synectics has higher revenue and earnings than MYCELX Technologies. Synectics is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Synectics£68.10M0.49£2.93M£21.808.92
MYCELX Technologies£11.74M1.04-£4.52M£1.0050.13

MYCELX Technologies has a net margin of 2.84% compared to Synectics' net margin of 1.29%. MYCELX Technologies' return on equity of 7.39% beat Synectics' return on equity.

Company Net Margins Return on Equity Return on Assets
Synectics1.29% 1.64% 5.02%
MYCELX Technologies 2.84%7.39%-24.82%

In the previous week, Synectics had 1 more articles in the media than MYCELX Technologies. MarketBeat recorded 2 mentions for Synectics and 1 mentions for MYCELX Technologies. Synectics' average media sentiment score of 0.80 beat MYCELX Technologies' score of 0.00 indicating that Synectics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Synectics
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MYCELX Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

8.9% of Synectics shares are owned by institutional investors. Comparatively, 18.1% of MYCELX Technologies shares are owned by institutional investors. 22.8% of Synectics shares are owned by company insiders. Comparatively, 30.4% of MYCELX Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

MYCELX Technologies beats Synectics on 7 of the 13 factors compared between the two stocks.

Get MYCELX Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for MYX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MYX vs. The Competition

MetricMYCELX TechnologiesCommercial Services & Supplies IndustryIndustrials SectorLON Exchange
Market Cap£12.21M£4.26B£10.62B£2.92B
Dividend YieldN/A5.06%97.24%6.17%
P/E Ratio50.1329.5526.47367.27
Price / Sales1.041,276.06357.2983,460.67
Price / Cash1.9622.4424.3427.89
Price / Book1.964.204.487.12
Net Income-£4.52M£146.68M£611.55M£5.89B
7 Day Performance10.18%0.22%-0.88%0.74%
1 Month Performance-7.16%2.38%2.25%3.13%
1 Year Performance87.06%5.72%11.33%22.34%

MYCELX Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MYX
MYCELX Technologies
N/AGBX 50.13
+1.3%
N/A+86.4%£12.21M£11.74M50.13N/A
GRA
Grafenia
N/AN/AN/AN/A£41.93M£11.68MN/A92
WYG
WYG
N/AN/AN/AN/A£39.97M£154.43MN/A1,612
CTG
Christie Group
N/AGBX 153
+0.3%
N/A+25.1%£39.21M£70.60M30.243,450
INCE
The Ince Group
N/AGBX 10.34
-0.6%
N/AN/A£37.96M£102.47M11.89700

Related Companies and Tools


This page (LON:MYX) was last updated on 8/25/2026 by MarketBeat.com Staff.
From Our Partners